Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP818256.RAg-UqhFH8Fv0dnH4NZxT78hbS0qQHGdG7E-ASbjlFRDA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP818256.RAg-UqhFH8Fv0dnH4NZxT78hbS0qQHGdG7E-ASbjlFRDA130_assertion type Assertion NP818256.RAg-UqhFH8Fv0dnH4NZxT78hbS0qQHGdG7E-ASbjlFRDA130_head.
- NP818256.RAg-UqhFH8Fv0dnH4NZxT78hbS0qQHGdG7E-ASbjlFRDA130_assertion description "[Here, we investigate how a truncated, constitutively active ErbB2 receptor (DeltaNErbB2) common in breast cancer impacts on the Na(+)/H(+)-exchanger NHE1 and the Na(+),HCO(3)(-)-cotransporter NBCn1 in MCF-7 human breast cancer cells and address the roles of these transporters in chemotherapy resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP818256.RAg-UqhFH8Fv0dnH4NZxT78hbS0qQHGdG7E-ASbjlFRDA130_provenance.
- NP818256.RAg-UqhFH8Fv0dnH4NZxT78hbS0qQHGdG7E-ASbjlFRDA130_assertion evidence source_evidence_literature NP818256.RAg-UqhFH8Fv0dnH4NZxT78hbS0qQHGdG7E-ASbjlFRDA130_provenance.
- NP818256.RAg-UqhFH8Fv0dnH4NZxT78hbS0qQHGdG7E-ASbjlFRDA130_assertion SIO_000772 20542029 NP818256.RAg-UqhFH8Fv0dnH4NZxT78hbS0qQHGdG7E-ASbjlFRDA130_provenance.
- NP818256.RAg-UqhFH8Fv0dnH4NZxT78hbS0qQHGdG7E-ASbjlFRDA130_assertion wasDerivedFrom befree-2016 NP818256.RAg-UqhFH8Fv0dnH4NZxT78hbS0qQHGdG7E-ASbjlFRDA130_provenance.
- NP818256.RAg-UqhFH8Fv0dnH4NZxT78hbS0qQHGdG7E-ASbjlFRDA130_assertion wasGeneratedBy ECO_0000203 NP818256.RAg-UqhFH8Fv0dnH4NZxT78hbS0qQHGdG7E-ASbjlFRDA130_provenance.